Join our market chat sessions every Tuesday and Thursday at 4:00 pm Pacific time!
More information on subscriber services can be found at http://www.technicalwatch.com/subs.htm
BioInvent enters collaboration with Genentech to develop and commercialize BioInvent´s proprietary antibody for the potential treatment of cardiovascular diseases [2007-01-12 8:30
Supported videos include:
Copyright 2000-2017 Technical Watch